Serina Therapeutics, Inc.·4

Apr 3, 8:59 PM ET

MINTZ STEVEN 4

4 · Serina Therapeutics, Inc. · Filed Apr 3, 2024

Insider Transaction Report

Form 4
Period: 2024-04-01
MINTZ STEVEN
Director
Transactions
  • Award

    Stock Option (right to buy)

    2024-04-01+40,00041,812 total
    Exercise: $11.83Exp: 2034-04-01Common Stock (40,000 underlying)
Footnotes (2)
  • [F1]The stock options vest in three equal installments on April 1, 2025, April 1, 2026 and April 1, 2027, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.
  • [F2]Number of derivative securities determined after giving effect to a reverse split of the Issuer's common stock of 1-for-35.17.

Documents

1 file
  • 4
    ownership.xmlPrimary